Cargando…
Liuwei Dihuang pill treats diabetic nephropathy in rats by inhibiting of TGF-β/SMADS, MAPK, and NF-kB and upregulating expression of cytoglobin in renal tissues
Liuwei Dihuang pill (LDP) was assessed for its effects on renal deficiency. 90 STZ induced DN rats were divided into groups (n = 22) without treatment (STZ) and LDP treated (STZ-L) (n = 23), Zhenwu decoction treated (STZ-Z) (n = 22), and valsartan treated (STZ-V) (n = 23) groups, with 16 normal cont...
Autores principales: | Xu, Zhong Ju, Shu, Shi, Li, Zhi Jie, Liu, Yu Min, Zhang, Rui Yi, Zhang, Yue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5279091/ https://www.ncbi.nlm.nih.gov/pubmed/28099346 http://dx.doi.org/10.1097/MD.0000000000005879 |
Ejemplares similares
-
Mechanism of Liuwei Dihuang Pills in treating osteoporosis based on network pharmacology
por: Wang, Xiqoqiang, et al.
Publicado: (2023) -
Liuwei Dihuang Pill Attenuates Diabetic Nephropathy by Inhibiting Renal Fibrosis via TGF-β/Smad2/3 Pathway
por: Shu, Shi, et al.
Publicado: (2022) -
Retracted: Liuwei Dihuang Pill Attenuates Diabetic Nephropathy by Inhibiting Renal Fibrosis via TGF-β/Smad2/3 Pathway
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023) -
The Role of Liuwei Dihuang Pills and Ginkgo Leaf Tablets in Treating Diabetic Complications
por: Zhao, Yue, et al.
Publicado: (2016) -
Exploring the Molecular Mechanism of Liuwei Dihuang Pills for Treating Diabetic Nephropathy by Combined Network Pharmacology and Molecular Docking
por: Wang, Gaoxiang, et al.
Publicado: (2021)